Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

About this update from Clover Health Investments, Corp.

CA-enabled PCPs showed better HEDIS® post-acute performance, including 33% higher discharge information receipt and an 11% higher rate of post-discharge medication reconciliation, underscoring the role of AI-enabled workflows in high-risk care transitions SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or "Clover Health"), and a leading AI-powered physician enablement platform, today released findings within the whitepaper  "Clinical Excellence in Continuity of Care: A Real-World Analysis of Counterpart Assistant's Role in Post-Hospitalization Follow-up." The whitepaper examines the relationship between CA use by primary care physicians ("PCPs") and performance on high-risk care transition outcomes, including two HEDIS®1 quality measures within Clover Health's Medicare Advantage population: Transitions of Care ("TRC") and Follow-Up After Emergency Department Visit for People with Multiple High-Risk Chronic Conditions ("FMC"). Counterpart Health partners with payers and provider organizations to help primary care teams identify care gaps, manage risk, and improve quality and financial performance across populations with complex clinical needs. For transitions of care, CA helps turn acute utilization events into timely, trackable follow-up work by generating tasks after hospital discharge and surfacing available hospitalization information, including medication information, lab results, procedures, and discharge summaries, within clinicians' existing workflows. "Patients are at their most vulnerable when they are discharged from the hospital, where communication gaps and missed follow-ups with their PCP can lead to avoidable complications," said David Tsay, MD, PhD, Chief Medical Officer at Counterpart Health and co-author of the whitepaper. "CA is supporting PCPs in ensuring follow-up care happens, and that patients are getting the proactive and longitudinal care they need." Key highlights from the whitepaper include:

View stock analysis, news, and events for Clover Health Investments, Corp.